Huntingdon slashing 100 jobs in U.K.; Clinical trial outcomes at the end of the world;

> Huntingdon Life Sciences, a U.K. CRO, is planning to cut 8% of its workforce, or about 100 jobs, to survive dwindling demand. News

> Indian regulators are considering forcing the closure of more than 50 pharma and CMO plants in Andhra Pradesh. Article

> S&P predicts that Quintiles can sustain its organic growth and snatch up even more market share in 2013. Story

> Avid Bioservices has completed all of its manufacturing upgrades, designed to help it commercialize Peregrine's bavituximab and Cotara. Item

> INC Research has notched its 500th QuickStart Camp enrollment, celebrating a program designed to help investigators plan accurate and efficacious studies. Release

> Presented with minimal comment: a Canadian Medical Association Journal analysis on how Mayan doomsday would (or will, if you're into that) affect outcomes in clinical trials. Study

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.

PRA Health has hired a former FDA clinical research lead to help run its decentralized study unit.

Big Pharma AstraZeneca and academic partner the University of Oxford are tapping research services firm CCT for their COVID-19 shot tests in Arizona.